TY - JOUR
T1 - Inhibition of immune synapse by altered dendritic cell actin distribution
T2 - A new pathway of mesenchymal stem cell immune regulation
AU - Aldinucci, Alessandra
AU - Rizzetto, Lisa
AU - Pieri, Laura
AU - Nosi, Daniele
AU - Romagnoli, Paolo
AU - Biagioli, Tiziana
AU - Mazzanti, Benedetta
AU - Saccardi, Riccardo
AU - Beltrame, Luca
AU - Massacesi, Luca
AU - Cavalieri, Duccio
AU - Ballerini, Clara
PY - 2010/11/1
Y1 - 2010/11/1
N2 - Immune synapse formation between dendritic cells (DCs) and T cells is one of the key events in immune reaction. In immunogenic synapses, the presence of fully mature DCs is mandatory; consequently, the modulation of DC maturation may promote tolerance and represents a valuable therapeutic approach in autoimmune diseases. In the field of cell therapy, bone marrow mesenchymal stem cells (MSCs) have been extensively studied for their immunoregulatory properties, such as inhibiting DC immunogenicity duringinvitro differentiation and amelioratinginvivo models of autoimmune diseases (e.g., experimental allergic encephalomyelitis). MSCs seem to play different roles with regard to DCs, depending on cell concentration, mechanismofstimulation, and accompanying immune cells. The aim of this work was to elucidate the immunogenic effects of MSC/DC interactions during DC activation (LPS stimulation or Ag loading). Human monocyte-derived DCs, bone marrow-derived MSCs, and circulating lymphocytes obtained from healthy donors, as well as the laboratory-generated influenza virus hemagglutinin-derived peptide, aa 306-318 peptide-specific T cell line were used for this study. We demonstrate that MSCs mediate inhibition of DC function only upon cell-cell contact. Despite no modification observed in cell phenotype or cytokine production, MSC-treated DCs were unable to form active immune synapses; they retained endocytic activity and podosome-like structures, typical of immature DCs. The transcriptional program induced by MSC-DC direct interaction supports at the molecular pathway level the phenotypical features observed, indicating the genes involved into contact-induced rearrangement of DC cytoskeleton.
AB - Immune synapse formation between dendritic cells (DCs) and T cells is one of the key events in immune reaction. In immunogenic synapses, the presence of fully mature DCs is mandatory; consequently, the modulation of DC maturation may promote tolerance and represents a valuable therapeutic approach in autoimmune diseases. In the field of cell therapy, bone marrow mesenchymal stem cells (MSCs) have been extensively studied for their immunoregulatory properties, such as inhibiting DC immunogenicity duringinvitro differentiation and amelioratinginvivo models of autoimmune diseases (e.g., experimental allergic encephalomyelitis). MSCs seem to play different roles with regard to DCs, depending on cell concentration, mechanismofstimulation, and accompanying immune cells. The aim of this work was to elucidate the immunogenic effects of MSC/DC interactions during DC activation (LPS stimulation or Ag loading). Human monocyte-derived DCs, bone marrow-derived MSCs, and circulating lymphocytes obtained from healthy donors, as well as the laboratory-generated influenza virus hemagglutinin-derived peptide, aa 306-318 peptide-specific T cell line were used for this study. We demonstrate that MSCs mediate inhibition of DC function only upon cell-cell contact. Despite no modification observed in cell phenotype or cytokine production, MSC-treated DCs were unable to form active immune synapses; they retained endocytic activity and podosome-like structures, typical of immature DCs. The transcriptional program induced by MSC-DC direct interaction supports at the molecular pathway level the phenotypical features observed, indicating the genes involved into contact-induced rearrangement of DC cytoskeleton.
UR - http://www.scopus.com/inward/record.url?scp=78149483011&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78149483011&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1001332
DO - 10.4049/jimmunol.1001332
M3 - Article
C2 - 20889545
AN - SCOPUS:78149483011
VL - 185
SP - 5102
EP - 5110
JO - Journal of Immunology
JF - Journal of Immunology
SN - 0022-1767
IS - 9
ER -